ArticleAnnals of clinical and translational neurology2021
Experiences of telemedicine in neurological out-patient clinics during the COVID-19 pandemic.
Article in Annals of clinical and translational neurology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 33 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
33 citing papers in PubMed, 64 citations in OpenAlex.
- One-Year Remission Rate of Chronic Headache Comparing Video and Face-to-Face Consultations by Neurologist: Randomized Controlled Trial.Journal of medical Internet research · 2021Trial
- Telehealth adoption and use intentions among neurologists in Saudi Arabia: a cross-sectional study.Frontiers in public health · 2026Article
- Telecoaching and Migraine: Digital Approach to Physical Activity in Migraine Management. A Scoping Review.Journal of clinical medicine · 2025Review
- Article
- Mobile Health Clinics and Telehealth Outreach in Thailand: A Focus on Elderly Care and NCDs.Journal of multidisciplinary healthcare · 2025Review
- The PopHEAD study: a population-based, cross-sectional study on headache burden in Norway: methods and validation of questionnaire-based diagnoses.The journal of headache and pain · 2024Article
- The impact of COVID-19 on people with epilepsy: Global results from the coronavirus and epilepsy study.Epilepsia open · 2024Article
- Era of COVID-19 in Multiple Sclerosis Care.Neurologic clinics · 2024Review
- Evolving migraine management: Lithuania's telemedicine experience.Frontiers in neurology · 2024Article
- Smartphone tests quantify lower extremities dysfunction in multiple sclerosis.Frontiers in neurology · 2024Article
- Exploring patients' views on telephone consultations in the seizure clinic: A qualitative interview study.Epilepsy & behavior reports · 2024Article
- Telemedicine in Headache Medicine: A Narrative Review.Current pain and headache reports · 2023Review
- Neurological Consequences of COVID-19: A Systematic Review of the Pandemic's Impact on Neurology Training.Brain sciences · 2023Review
- Physicians' views on optimal use and payment system for telemedicine: a qualitative study.BMC health services research · 2023Article
- Experience and perception of utilizing virtual clinic in neurological assessment in Saudi Arabia.Frontiers in neurology · 2023Article
- Telemedicine in the Management of Parkinson's Disease: Achievements, Challenges, and Future Perspectives.Brain sciences · 2022Article
- The First Case Series From Japan of Primary Headache Patients Treated by Completely Online Telemedicine.Cureus · 2022Article
- Potential clinical and economic benefits of remote deep brain stimulation programming.Scientific reports · 2022Article
- Current care practices for patients with Duchenne muscular dystrophy in China.Brain & development · 2022Article
- Moving towards intelligent telemedicine: Computer vision measurement of human movement.Computers in biology and medicine · 2022Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors at 4 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveThe COVID-19 pandemic has led to rapid changes in the delivery of medical care worldwide. The main objective of this survey was to investigate the initial experiences of neurologists with the use of telemedicine for different neurological conditions during the first phase of the COVID-19.
methodsAll hospital-based neurologists in Norway (n = 400) were invited to a questionnaire survey by e-mail in April 2020. The study focused on telemedicine and all questions were answered with regard to the first weeks of the pandemic lockdown in Norway.
resultsOne-hundred and thirty-five neurologists responded. Overall, 87% reported a shift toward more telemedicine, with significantly more use of telephone than video consultations for both new referrals (54% vs. 30%, P < 0.001) and follow-ups (99% vs. 50%, P < 0.001). Respondents deemed it much more professionally satisfactory to conduct follow-up consultations by telephone, than to carry out consultations with new patients by telephone (85% vs. 13%, P < 0.001). Teleconsultations were better suited for headache and epilepsy patients as compared to multiple sclerosis and movement disorder patients. There was no significant difference between residents and senior consultants regarding how they experienced teleconsultations. Female neurologists found telemedicine better and more effective than male neurologists.
interpretationTelemedicine was rapidly implemented in Norwegian neurological departments during the first weeks of the COVID-19 pandemic. Teleconsultations were better suited for follow-ups than for new referrals, and better for headache and epilepsy patients as compared to multiple sclerosis and movement disorder patients.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.